Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
View ORCID ProfileWinston A. Haynes, Kathy Kamath, Carolina Lucas, John Shon, Akiko Iwasaki
doi: https://doi.org/10.1101/2021.01.06.20248960
Winston A. Haynes
1Serimmune, Inc., Goleta, CA, USA
Kathy Kamath
1Serimmune, Inc., Goleta, CA, USA
Carolina Lucas
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
John Shon
1Serimmune, Inc., Goleta, CA, USA
Akiko Iwasaki
2Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
3Howard Hughes Medical Institute, Chevy Chase, MD, USA
Data Availability
Data available upon request.
Posted January 08, 2021.
Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
Winston A. Haynes, Kathy Kamath, Carolina Lucas, John Shon, Akiko Iwasaki
medRxiv 2021.01.06.20248960; doi: https://doi.org/10.1101/2021.01.06.20248960
Subject Area
Subject Areas
- Addiction Medicine (363)
- Allergy and Immunology (683)
- Anesthesia (183)
- Cardiovascular Medicine (2722)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12371)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4223)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2726)
- Health Policy (1013)
- Hematology (369)
- HIV/AIDS (873)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4001)
- Nursing (216)
- Nutrition (592)
- Oncology (2110)
- Ophthalmology (602)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1143)
- Primary Care Research (465)
- Public and Global Health (6626)
- Radiology and Imaging (1439)
- Respiratory Medicine (882)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (460)
- Toxicology (57)
- Transplantation (192)
- Urology (171)